Quipt Home Medical (NASDAQ:QIPT) & Avivagen (OTCMKTS:VIVXF) Head to Head Review

Quipt Home Medical (NASDAQ:QIPT) and Avivagen (OTCMKTS:VIVXF) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Quipt Home Medical and Avivagen, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quipt Home Medical	2	1	1	0	1.75
Avivagen	0	0	0	0	0.00

Quipt Home Medical presently has a consensus price target of $3.83, indicating a potential upside of 6.84%. Given Quipt Home Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe Quipt Home Medical is more favorable than Avivagen.

Insider and Institutional Ownership

42.9% of Quipt Home Medical shares are held by institutional investors. 13.4% of Quipt Home Medical shares are held by company insiders. Comparatively, 2.1% of Avivagen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Quipt Home Medical and Avivagen’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quipt Home Medical	-4.38%	-10.13%	-4.27%
Avivagen	N/A	N/A	N/A

Earnings & Valuation

This table compares Quipt Home Medical and Avivagen”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quipt Home Medical	$245.40 million	0.64	-$10.70 million	($0.25)	-14.32
Avivagen	N/A	N/A	N/A	($0.04)	N/A

Avivagen has lower revenue, but higher earnings than Quipt Home Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Avivagen, indicating that it is currently the more affordable of the two stocks.

Summary

Quipt Home Medical beats Avivagen on 6 of the 10 factors compared between the two stocks.

About Quipt Home Medical

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

About Avivagen

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.